Effect of Intrathecal Injection of Bovineadrenalmedulla 8-22 on Pain Behavior in a Mouse Model of Bone Cancer Pain
Sun Yu'e,Lu Cui'e,Lei Yishan,Gu Xiaoping,Ma Zhengliang
DOI: https://doi.org/10.3760/cma.j.issn.1001-9030.2018.05.032
2018-01-01
Abstract:Objective To investigate the effect of intrathecal injection bovineadrenalmedulla 8-22 (BAM8-22) on pain behavior in a mouse model of bone cancer pain.Methods 50 male 8-10 week old C3H/HeJ mice weighing 18-22 g were divided randomly into 5 groups (n =8):sham group (S group),BCP group:artificial cerebrospinal fluid treat group (B0 group) and BAM8-22 treat groups (B1-B3 group).Group C and B were induced mouse models of bone cancer pain by intra-right-femur inoculations of osteolytic NCTC2472 cells while group S were injected only α-MEM.On the 14 d after inoculations,group S and BCP received intrathecal injection of artificial cerebrospinal fluid 5 μl,while group B1-B3 received intrathecal injection of BAM8-22 0.8,2.4,8.0 nmol,which dissolved in 5 μl artificial cerebrospinal fluid.They were intrathecally injected,respectively,once a day for 7 consecutive days starting from day 14 after inoculation.Mice received pain behavior tests including quantification of spontaneous flinches (NSF),paw withdrawal mechanical threshold (PWMT) 0.5 h before and at 2 h,after administration.Results Compared with S group [(1.80±0.20) times,(1.87 ±0.22) g],NSF [(14.67±2.65) times] was significantly increased (P =0.000) and MWT [(0.42 ± 0.22) g] was significantly decreased (P =0.002) on 7-21 days after inoculation in BCP group.Compared with B0 group [(12.38 ±1.12) times,(0.48 ± 0.22) g] and the basal level on 14th day before administration [(12.65 ±1.10) times,(0.46 ±0.19) g,P=0.012,0.011,0.001,0.001],PWMT was significantly decreased,and NSF was increased at 2 h after administration in B2 group [(7.28 ±0.82) times,(1.01 ±0.13) g] and B3 groups [(4.18 ±1.02) times,(1.38 ±0.12) g,P=0.027,0.025,0.013,0.009].The analgesic effect of group B3 was more conspicuous compared with group B2 (P =0.007,0.031).No obvious change of pain ethology indexes wag observed in group B1 [(12.03 ± 1.22) times,(0.51 ± 0.16) g] (P =0.096,0.074,0.527,0.474).Conclusion Intrathecal BAM8-22 injection can effectively attenuated bone cancer pain with increased doses in the mouse model of bone cancer pain.